TGTX PEER ANALYSIS

TG Therapeutics Inc — metric-by-metric comparison with peers and the industry median

TGTXTG Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

TGTXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	TGTX	TLX	CSL	MSB	Ind. Median
P/E	20.12●	—	29.96	—	18.06
P/B	15.94	6.38	2.24●	—	3.62
EV/EBITDA	63.47	120.20	10.35●	—	15.13
P/S	13.27	3.24	2.66●	31.30	10.65

Financial Health
Metric	TGTX	TLX	CSL	MSB	Ind. Median
Current Ratio	5.81●	1.43	2.57	—	5.90
Debt/Equity	129.2%	112.3%	67.4%●	—	10.9%
NetDebt/EBITDA	1.59●	13.13	2.22	—	1.15

Profitability
Metric	TGTX	TLX	CSL	MSB	Ind. Median
Net Margin	66.0%●	-0.9%	9.2%	-115.3%	-125.7%
ROE	112.6%●	-1.8%	7.7%	-11.3%	-47.5%
ROA	42.3%●	-0.7%	3.8%	-8.6%	-35.8%
EBITDA Margin	21.4%	3.0%	32.8%●	-76.6%	-105.8%

Growth + Dividend
Metric	TGTX	TLX	CSL	MSB	Ind. Median
Rev. Growth	81.3%	56.3%	4.8%	410.4%●	5.1%
NI Growth	1,079.8%●	—	-39.4%	—	12.1%
Div. Yield	0.0%	—	2.5%●	0.0%	0.2%
Payout	0.0%	—	103.1%	0.0%	0.0%

Valuation
Metric	TGTX	PCVX	SMMT	IMVT	APGE	PTGX	Ind. Median
P/E	20.12	—	—	—	—	—	18.06
P/B	15.94	2.83●	22.30	9.58	7.41	15.15	3.62
EV/EBITDA	63.47	—	—	—	—	—	15.13
P/S	13.27●	—	—	—	—	134.06	10.65

Financial Health
Metric	TGTX	PCVX	SMMT	IMVT	APGE	PTGX	Ind. Median
Current Ratio	5.81	7.49	7.41	9.09	32.59●	17.76	5.90
Debt/Equity	129.2%	3.9%	3.7%	0.0%●	0.6%	1.5%	10.9%
NetDebt/EBITDA	1.59	1.76	0.69●	1.79	3.86	4.72	1.15

Profitability
Metric	TGTX	PCVX	SMMT	IMVT	APGE	PTGX	Ind. Median
Net Margin	66.0%●	—	—	—	—	-154.9%	-125.7%
ROE	112.6%●	-30.6%	-256.3%	-64.8%	-28.5%	-17.1%	-47.5%
ROA	42.3%●	-28.1%	-221.2%	-58.3%	-27.4%	-15.9%	-35.8%
EBITDA Margin	21.4%●	—	—	—	—	-153.8%	-105.8%

Growth + Dividend
Metric	TGTX	PCVX	SMMT	IMVT	APGE	PTGX	Ind. Median
Rev. Growth	81.3%●	—	—	-100.0%	-100.0%	-64.4%	5.1%
NI Growth	1,079.8%	—	—	—	—	—	12.1%
Div. Yield	0.0%	—	—	—	—	—	0.2%
Payout	0.0%	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on TGTX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.